# CLENON ENT (NSE: CLENON) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/CLENON · Pivot · prices to 21 Oct 2026

With a market capitalisation of ₹51 Cr, it ranks 3064th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Telecom sector; its industry is Shell Companies.

Its return on equity was −33.1% in FY26.

## Key numbers

| Metric | Value |
| --- | --- |
| Market cap | ₹51 Cr |
| ROE | −33.1% (FY26) |
| ROCE | −16.9% (FY26) |
| Debt to equity | 0.94 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY08 | ₹10 Cr | −₹5 Cr |
| FY07 | ₹25 Cr | −₹1 Cr |

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Gradiente Infotainment](https://app.pivotnow.in/stock/GRADIENTE) | ₹2.38 | ₹79 Cr | — | — |
| [Touchwood Entertainment](https://app.pivotnow.in/stock/TOUCHWOOD) | ₹57.94 | ₹64 Cr | 15.8 | — |
| [Odigma Consultancy Solutions](https://app.pivotnow.in/stock/ODIGMA) | ₹19.86 | ₹62 Cr | — | — |
| [Tamilnadu Telecommunication](https://app.pivotnow.in/stock/TNTELE) | ₹12.84 | ₹59 Cr | — | — |
| [Jupiter Infomed](https://app.pivotnow.in/stock/JUPITERIN) | — | ₹54 Cr | — | — |
| [Nettlinx](https://app.pivotnow.in/stock/NETTLINX) | — | ₹39 Cr | — | — |

## Questions and answers

### What is the market cap of CLENON ENT?

CLENON ENT's market capitalisation is ₹51 Cr (₹51 Cr) at the 21 Oct 2026 close, ranking 3064th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of CLENON ENT?

Return on equity was −33.1% in FY26 and return on capital employed was −16.9% in FY26 (consolidated figures).

### Is CLENON ENT a debt-free company?

No. CLENON ENT's debt-to-equity ratio was 0.94 in FY26, with total debt of ₹7 Cr.

### Who are CLENON ENT's competitors?

The listed Telecom companies closest to CLENON ENT by market cap are Gradiente Infotainment, Touchwood Entertainment, Odigma Consultancy Solutions, Tamilnadu Telecommunication, Jupiter Infomed and Nettlinx.

### Is CLENON ENT a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out CLENON ENT's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on CLENON against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.